Biotech is the only place I am finding compelling values in this market – already have the trade in for GILD, but AMGN merits further research:
| Ticker | Price | Fair Value | Margin of Safety | Yield % |
| AMGN | $155.63 | $194.00 | $38.37 | 2.2% |
| WMT | $69.02 | $75.00 | $5.98 | 2.9% |
| MMP | $70.34 | 76 | $5.66 | 4.3% |
Click on the links to research further.
WMT and MMP are too expensive right now – but could be worth a trade in a market downturn.
Results are based on the following screen:
- Low fair value uncertainty.
- Wide moat.
- Morningstar rating 4 or more stars.
- Financial Health Grade >= B.
- Current P/E <= 20.
Leave a Reply